5MJC BCU 13: Tyrosine Kinases as Targets for Cancer Therapy | Research To Practice
Clinical development of targeted and immune based anti-cancer therapies | Journal of Experimental & Clinical Cancer Research | Full Text
Receptor Tyrosine Kinase - Creative Diagnostics
Mechanism of action of BCR (breakpoint cluster region)-ABL (Abelson 1... | Download Scientific Diagram
Non-Receptor Tyrosine Kinase - an overview | ScienceDirect Topics
Schematic representation of mechanism of action of tyrosine kinase... | Download Scientific Diagram
PDF] Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence. | Semantic Scholar
Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms in: Endocrine-Related Cancer Volume 25 Issue 9 (2018)
Mechanisms of receptor tyrosine kinase activation in cancer | Molecular Cancer | Full Text
Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective | Journal of Experimental & Clinical Cancer Research | Full Text
Cancers | Free Full-Text | Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy | HTML
Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia - The American Journal of Pathology
Exploring receptor tyrosine kinases-inhibitors in Cancer treatments | Egyptian Journal of Medical Human Genetics | Full Text